Cell Therapeutics · Clinical & Translational Platform

Expanding Access to Islet Cell Therapies

IsleNova Cell Therapeutics is committed to advancing the future of islet cell therapeutics and regenerative medicine by expanding access to specialized clinical cell therapy services. We support physicians and their patients through high-quality islet cell isolation, integrated procedural support, and FDA cGTP-aligned processing capabilities.

Explore our platformFor physicians →
Clinical focus
Islet cell processing
End-to-end
Procedural support
cGTP-aligned
Processing standards
Translational
R&D platform
What we do

A specialized clinical cell therapy platform

Clinical islet isolation
High-quality islet cell isolation for clinical cell replacement procedures.
Procedural support
Back-table procurement, transport logistics, processing, and infusion coordination.
Processing infrastructure
cGTP-aligned facilities and protocols for clinical cell therapies.
Translational innovation
Development of next-generation regenerative and autologous cell therapy approaches.

Platform development roadmap

IsleNova combines clinical service capabilities with long-term regenerative cell therapy development.

Clinical Services
Islet cell processing platform

Supporting surgical teams through specialized cell isolation and procedural workflows.

In Development
Regenerative cell therapy platform

Development of autologous cell-based therapies using islet-derived cell populations.

Connect with IsleNova

For physicians & institutions

Explore partnership opportunities for clinical cell therapy programs and procedural support for your patients.

Register interest →
For investors

Early-stage opportunity combining clinical services with long-term regenerative therapy development.

Investor overview →